“…In an effort to isolate effects from disability, litigation, and expectation/attribution, Bell et al (14)(15)(16)(17)(18)(19) initiated a series of studies focused on chemical intolerance in high-functioning older and young adults from the community who were not clinically ill. Findings in these preclinical chemical intolerant individuals, who constituted 15-30% of the general population samples, included life histories of medical problems that overlapped with those of MCS/IEI patients (10,17,19), increased trait shyness (14,15,17), objectively lower total sleep times (20), evaluation of plasma beta-endorphins (21), alterations in spectral electroencephalographic patterns during chemical exposure (22) and reduced reaction times on divided-attention tasks (23).…”